Skip to content

Clinical trials

Phase 3 Kidney Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Diseases Phase: Phase 3 Country / region: Germany Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20061
20072
20091
20101
20112
20121
20142
20152
20161
20171
20191
20201
20221
20232
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting5
Recruiting4
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
AstraZeneca2
Bayer2
Eli Lilly and Company2
Novartis Pharmaceuticals2
Sankyo Pharma Gmbh2
Takeda2
University of Leipzig2
Atrial Fibrillation Network1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Diseases27
Renal Insufficiency, Chronic9
Diabetes Mellitus, Type 26
Diabetic Nephropathies4
Glomerulonephritis3
Hypertension3
Kidney Failure, Chronic3
Urologic Diseases3
Cardiovascular Diseases2
Glomerulonephritis, IGA2

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.